Jinyu Xia to Coronavirus Infections
This is a "connection" page, showing publications Jinyu Xia has written about Coronavirus Infections.
Connection Strength
0.110
-
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study. Trials. 2020 Jul 08; 21(1):622.
Score: 0.028
-
Psychological status and behavior changes of the public during the COVID-19 epidemic in China. Infect Dis Poverty. 2020 May 29; 9(1):58.
Score: 0.028
-
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study. J Infect. 2020 07; 81(1):e1-e5.
Score: 0.027
-
Comparison of clinical characteristics between fecal/perianal swab nucleic acid-positive and -negative patients with COVID-19. J Infect Dev Ctries. 2020 08 31; 14(8):847-852.
Score: 0.007
-
Treating COVID-19 with Chloroquine. J Mol Cell Biol. 2020 05 18; 12(4):322-325.
Score: 0.007
-
Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study. Am J Chin Med. 2020; 48(4):779-792.
Score: 0.007
-
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 03 19; 382(12):1177-1179.
Score: 0.007